Hui Gao
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- biodegradable polymer synthesis and properties
- Molecular Medicine top 1%
Papers in
-
- Nanoplatforms for cancer theranostics 44
-
- Advanced biosensing and bioanalysis techniques 24
- RNA Interference and Gene Delivery 20
- Co-authors
- Jianbiao Ma (52 shared papers)Ying‐Wei Yang (28 shared papers)James M. Reuben (42 shared papers)Guolin Wu (30 shared papers)Yinong Wang (26 shared papers)Hongguang Lu (20 shared papers)Evan N. Cohen (27 shared papers)Qinglan Li (6 shared papers)
- Journals
- Journal of Materials Chemistry B (17 papers)Journal of Controlled Release (10 papers)Cancer Research (10 papers)ACS Applied Materials & Interfaces (9 papers)RSC Advances (7 papers)
- Partner nations
- ChinaUnited StatesEgypt
In The Last Decade
Hui Gao
338 papers receiving 9.1k citations
Hui Gao's Hit Papers
Peers
Comparison fields: 5 of 161
- Biomaterials 1.9k
- Molecular Medicine 301
- Cancer Research 802
- Oncology 1.3k
- Surfaces, Coatings and Films 365
Countries citing papers authored by Hui Gao
This map shows the geographic impact of Hui Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Gao more than expected).
Fields of papers citing papers by Hui Gao
This network shows the impact of papers produced by Hui Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Gao. The network helps show where Hui Gao may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Gao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 357 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 311 | |
| 2 | 2015 | 285 | |
| 3 | 2011 | 283 | |
| 4 | 2017 | 269 | |
| 5 | 2014 | 184 | |
| 6 | Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials Hit paper breakdown → | 2022 | 153 |
| 7 | 2011 | 144 | |
| 8 | 2015 | 132 | |
| 9 | 2015 | 124 | |
| 10 | 2019 | 120 | |
| 11 | 2012 | 119 | |
| 12 | 2012 | 117 | |
| 13 | 2019 | 111 | |
| 14 | 2010 | 109 | |
| 15 | 2017 | 108 | |
| 16 | 2014 | 102 | |
| 17 | 2005 | 100 | |
| 18 | 2010 | 100 | |
| 19 | 2015 | 96 | |
| 20 | 2014 | 90 |
About Hui Gao
Hui Gao is a scholar working on Biomedical Engineering, Molecular Biology, Biomaterials, Oncology and Organic Chemistry, having authored 357 papers that have together received 9.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (44 papers), Nanoparticle-Based Drug Delivery (31 papers), Cancer Cells and Metastasis (26 papers), Advanced Polymer Synthesis and Characterization (24 papers), Advanced biosensing and bioanalysis techniques (24 papers), Luminescence and Fluorescent Materials (23 papers), RNA Interference and Gene Delivery (20 papers) and biodegradable polymer synthesis and properties (16 papers). The work is most often cited by research in Biomaterials (1.9k citations), Molecular Medicine (301 citations), Cancer Research (802 citations), Oncology (1.3k citations) and Surfaces, Coatings and Films (365 citations). Hui Gao has collaborated with scholars based in China, United States and Egypt. Frequent co-authors include Jianbiao Ma, Ying‐Wei Yang, James M. Reuben, Guolin Wu, Yinong Wang, Hongguang Lu, Evan N. Cohen, Qinglan Li, Yunge Fan and Qixian Chen. Their work appears in journals such as Journal of Materials Chemistry B, Journal of Controlled Release, Cancer Research, ACS Applied Materials & Interfaces and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.